Subtype
Malignant Urinary Tract Neoplasm
CI-CAN-00003252Explore in graph →
507 active trials14 approved drugs29 evidence items
- NCIt
- C192668
Loading cancer entity…
Subtype
CI-CAN-00003252Explore in graph →
Clinical trials
1,954 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (246)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04718948 | Multimodal Spectroscopy to Detect Urothelial Cancer in Urine | unknown | — | 500 | University of FlorenceOTHER | 1 | May 9, 2022 | clinicaltrials |
| NCT04770974 | Urothelial Cancer Tumor Bio-markers and Physical-spectroscopic Characteristic | unknown | — | 200 | University of FlorenceOTHER | 1 | May 9, 2022 | clinicaltrials |
| NCT05344937 |
| Validation Study of Uromonitor in High Risk Microhematuria Patients |
| unknown |
| — |
| 343 |
| Clinica Universidad de Navarra, Universidad de NavarraOTHER |
| 1 |
| May 2, 2022 |
| clinicaltrials |
| NCT03062059 | The Effectiveness and Safety of Intravesical Gemcitabine Instillation to Prevent Intravesical Recurrence | unknown | Phase 2 | 134 | National Cancer Center, KoreaOTHER_GOV | 1 | Apr 14, 2022 | clinicaltrials |
| NCT04339933 | Detection of FGFR Gene Mutations in the Tumor Tissue and Urine of Patients With Urothelial Carcinoma | unknown | — | 92 | Ho Kyung SeoOTHER_GOV | 0 | Apr 7, 2022 | clinicaltrials |
| NCT04876313 | An Open Label, Single-arm, Phase 2 Study of Neoadjuvant Nivolumab and Nab-paclitaxel Before Radical Cystectomy for Patients With Muscle-invasive Bladder Cancer (NURE-Combo)(NURE-Combo) | unknown | Phase 2 | 29 | IRCCS San RaffaeleOTHER | 1 | Apr 6, 2022 | clinicaltrials |
| NCT03759496 | Efficacy of Durvalumab in Non-muscle-invasive Bladder Cancer | unknown | Phase 2 | 39 | Hellenic GenitoUrinary Cancer GroupOTHER | 1 | Mar 23, 2022 | clinicaltrials |
| NCT03993249 | Nivolumab Plus Chemoradiotherapy in Patients With Muscle-invasive Bladder Cancer (MIBC) Not Undergoing Cystectomy | unknown | Phase 2 | 78 | Hellenic GenitoUrinary Cancer GroupOTHER | 1 | Mar 23, 2022 | clinicaltrials |
| NCT05077852 | Intravesical Prostatic Protrusion Mimicking Urothelial Cell Carcinoma of the Bladder | unknown | — | 194 | Ankara Training and Research HospitalOTHER | 1 | Mar 15, 2022 | clinicaltrials |
| NCT02994758 | Development of Diagnostics and Treatment of Urological Cancers(DEDUCER) | unknown | N/A | 100 | Helsinki University Central HospitalOTHER | 1 | Mar 11, 2022 | clinicaltrials |
| NCT03762161 | A Phase II Study of Lonsurf (TAS-102) in Metastatic Platinum and Checkpoint Inhibitor-resistant Bladder Cancer | unknown | Phase 2 | 22 | Rahul ParikhOTHER | 1 | Mar 10, 2022 | clinicaltrials |
| NCT02535650 | Study of Tipifarnib in Patients With Previously-Treated, Advanced, HRAS Mutant Urothelial Carcinoma | unknown | Phase 2 | 19 | Samsung Medical CenterOTHER | 1 | Mar 8, 2022 | clinicaltrials |
| NCT05262166 | Opioid Free Anesthesia in Prolonged Surgery | unknown | N/A | 34 | Mansoura UniversityOTHER | 1 | Mar 2, 2022 | clinicaltrials |
| NCT05235607 | Personalized Immune Cell Therapy Targeting Neoantigen of Malignant Solid Tumors | unknown | Phase 1 | 60 | Sichuan UniversityOTHER | 1 | Feb 11, 2022 | clinicaltrials |
| NCT05220124 | A Study of Probiotics Administration in the Immunotherapy of Urothelial Bladder Carcinoma | unknown | Phase 4 | 190 | Tianjin Medical University Second HospitalOTHER | 1 | Feb 2, 2022 | clinicaltrials |
| NCT05180851 | Safety and Efficacy of Recombinant Oncolytic Adenovirus L-IFN Injection in Relapsed/Refractory Solid Tumors Clinical Study(YSCH-01) | unknown | Early Phase 1 | 28 | Shanghai Fengxian District Central HospitalOTHER | 1 | Feb 1, 2022 | clinicaltrials |
| NCT04603846 | A Study of Anti-PD-L1 Antibody ZKAB001 Combined With Albumin-bound Paclitaxel in Advanced Urothelial Carcinoma | unknown | Phase 1 | 20 | Lee's Pharmaceutical LimitedINDUSTRY | 1 | Jan 24, 2022 | clinicaltrials |
| NCT02992990 | Bladder Tumor Biopsy Study to Improve Preoperative Determination of Stage and Grade | unknown | N/A | 30 | Baylor College of MedicineOTHER | 1 | Jan 19, 2022 | clinicaltrials |
| NCT05108077 | Treatment of Metastatic Tumors of the Urogenital Area With Cytokine-induced Killer Cells | unknown | Phase 1 / Phase 2 | 20 | Institute of Biophysics and Cell Engineering of National Academy of Sciences of BelarusOTHER_GOV | 1 | Jan 14, 2022 | clinicaltrials |
| NCT03715985 | Personalized Neo-antigen Vaccine in Advanced Solid Tumors (NeoPepVac)(NeoPepVac) | unknown | Phase 1 / Phase 2 | 12 | Herlev HospitalOTHER | 1 | Jan 11, 2022 | clinicaltrials |
| NCT05146635 | Optimal Adjuvant Intravesical Therapy for Intermediate Risk Non Muscle Invasive Bladder Cancer: A Randomized Controlled Trial | unknown | N/A | 110 | Mansoura UniversityOTHER | 1 | Jan 11, 2022 | clinicaltrials |
| NCT05167916 | Can Four Weeks-check Cystoscopy and Urine Cytology After Primary Complete Resection of T1 Bladder Cancer Replace Repeat Biopsy? | unknown | N/A | 200 | Mansoura UniversityOTHER | 1 | Dec 22, 2021 | clinicaltrials |
| NCT05160285 | Neoadjuvant Nivolumab for Upper Tract Urothelial Carcinoma | unknown | Phase 2 | 29 | YULISUOTHER | 1 | Dec 16, 2021 | clinicaltrials |
| NCT04839510 | A Study of MRG002 in the Treatment of HER2-positive Unresectable Locally Advanced or Metastatic Urothelium Cancer | unknown | Phase 2 | 58 | Shanghai Miracogen Inc.INDUSTRY | 1 | Dec 14, 2021 | clinicaltrials |
| NCT05148728 | Active Surveillance vs in Office Fulguration for Low Grade Bladder Cancer Tumors | unknown | N/A | 120 | Vall Hebron Insitut RecercaNETWORK | 1 | Dec 8, 2021 | clinicaltrials |
| NCT05123404 | Validation of VI-RADS for the Detection of Detrusor Muscle Invasion | unknown | N/A | 60 | Egyptian Biomedical Research NetworkNETWORK | 1 | Nov 17, 2021 | clinicaltrials |
| NCT05112523 | The Performance of Cancer Risk Genes in the Necessity of Secondary TURBT(RE-TURBT) | unknown | — | 200 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Nov 9, 2021 | clinicaltrials |
| NCT04730232 | Tilelizumab Combined With Nab-Paclitaxel for High-Risk Non-Muscle-Invasive Urothelial Bladder Carcinoma Which is Not Completely Resectable | unknown | Phase 2 | 63 | Tianjin Medical University Second HospitalOTHER | 1 | Oct 29, 2021 | clinicaltrials |
| NCT05097404 | Clinical Utility of VI-RADS in Diagnosis of MIBC | unknown | — | 73 | Samsung Medical CenterOTHER | 1 | Oct 28, 2021 | clinicaltrials |
| NCT05096533 | The Application Value of Artificial Intelligence in MRI Precision Diagnosis and Treatment of Bladder Cancer | unknown | — | 150 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Oct 27, 2021 | clinicaltrials |
| NCT05086666 | A Phase 1b/2 Clinical Study to Evaluate the Safety and Tolerability and Efficacy of AZD4547 | unknown | Phase 1 / Phase 2 | 108 | Abbisko Therapeutics Co, LtdINDUSTRY | 1 | Oct 21, 2021 | clinicaltrials |
| NCT04432909 | A Prospective, Multi-centre, Single-blinded Study of UroCAD for Urothelial Carcinoma Diagnosis and Follow-up | unknown | — | 500 | Changhai HospitalOTHER | 1 | Sep 16, 2021 | clinicaltrials |
| NCT05043662 | UroCAD Assay Combined With Computed Tomography Urography and Urine Cytology for UTUC Diagnosis. | unknown | — | 110 | Changhai HospitalOTHER | 1 | Sep 14, 2021 | clinicaltrials |
| NCT05030077 | Anlotinib Combined With Platinum/Gemcitabine for First Line Treatment of Advanced Urothelial Carcinoma | unknown | Phase 2 | 53 | Tianjin Medical University Second HospitalOTHER | 1 | Sep 1, 2021 | clinicaltrials |
| NCT05027412 | En Bloc TURBT With Collins Loop vs Conventional TURBT(TURBT) | unknown | N/A | 80 | Hospital Universitario de FuenlabradaOTHER | 1 | Aug 30, 2021 | clinicaltrials |
| NCT03864302 | Simulation in Transurethral Bladder Cancer Surgery(OSATURB) | unknown | N/A | 34 | Rigshospitalet, DenmarkOTHER | 1 | Aug 24, 2021 | clinicaltrials |
| NCT05018429 | Nerve Sparing Versus Non Nerve Sparing Robot-assisted Radical Cystectomy-orthotopic Ileal Neobladder for Bladder Cancer in the Male | unknown | — | 100 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Aug 24, 2021 | clinicaltrials |
| NCT05016973 | A Clinical Study of RC48-ADC Combined With Triplizumab For Treatment of Myometrial Invasive Bladder Cancer | unknown | Phase 2 | 25 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Aug 23, 2021 | clinicaltrials |
| NCT04815629 | Outcome of Radiation Therapy in Urinary Bladder Squampus Cell Carcinoma | unknown | — | 40 | Assiut UniversityOTHER | 0 | Aug 18, 2021 | clinicaltrials |
| NCT05001763 | Prucalopride for Postoperative Ileus in Patients Undergoing Robot-assisted Laparoscopic Radical Cystectomy | unknown | Phase 2 | 160 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 0 | Aug 12, 2021 | clinicaltrials |
| NCT04162704 | EpiCheck and Short-term Intensive Chemoresection in NMIBC | unknown | — | 22 | Aarhus University HospitalOTHER | 1 | Aug 11, 2021 | clinicaltrials |
| NCT04267575 | Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites | unknown | N/A | 20 | Jerome Canady, M.D.OTHER | 1 | Aug 9, 2021 | clinicaltrials |
| NCT04871334 | Safety, Tolerability and Pharmacokinetics of TWP-101 in Patients With Advanced Melanoma and Urothelial Carcinoma | unknown | Phase 1 | 76 | Shandong TheraWisdom Biopharma Co., Ltd.INDUSTRY | 1 | Jul 23, 2021 | clinicaltrials |
| NCT04966130 | Effect of Urinary Indwelling Time on Early Continence After Robot-assisted Radical Cystectomy With Orthotopic Ileal Neobladder. | unknown | — | 96 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 0 | Jul 19, 2021 | clinicaltrials |
| NCT04966949 | Lateral Prostate Capsule Sparing Versus Nerve Sparing Robot-assisted Radical Cystectomy-orthotopic Ileal Neobladder for Bladder Cancer in the Male | unknown | N/A | 100 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jul 19, 2021 | clinicaltrials |
| NCT04966962 | Establishment and Validation of an Early Diagnostic Model for Bladder Cancer Based on Serum and Urine Metabolomics | unknown | — | 180 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 0 | Jul 19, 2021 | clinicaltrials |
| NCT04966975 | Effect and Prognosis of Immunohistochemical Biomarkers Changes in Patients With Bladder Cancer After Neoadjuvant Chemotherapy | unknown | — | 60 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 0 | Jul 19, 2021 | clinicaltrials |
| NCT04958330 | Lateral Prostate Capsule Sparing Versus Non Nerve Sparing Robot-assisted Radical Cystectomy-orthotopic Ileal Neobladder for Bladder Cancer in the Male | unknown | — | 100 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jul 12, 2021 | clinicaltrials |
| NCT04958343 | Application and Clinical Effectiveness of Pelvic Reconstruction in Robot-assisted Radical Cystectomy-orthotopic Ileal Neobladder in the Male | unknown | — | 100 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jul 12, 2021 | clinicaltrials |
| NCT04939194 | Fast Track Protocol After Radical Cystectomy and Urinary Diversion: A Randomised Controlled Trial. | unknown | Phase 3 | 200 | Mansoura UniversityOTHER | 1 | Jun 25, 2021 | clinicaltrials |
Data updated 23 days agoSource updated May 9, 2022source: clinicaltrials